IRCCS Giovanni Paolo II Istituto Oncologico

Bari 70126

0 studies enrolling now · 3 studies all time

What they study most

Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV, Metastatic Pancreatic Cancer, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed